Pulmonary Vascular Resistance to Predict Right Heart Failure in Patients Undergoing Left Ventricular Assist Device Implantation

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Jan 23

PMID 38256596

Authors

Rene Schramm

Johannes Kirchner

Mohamad Ibrahim

Sebastian V Rojas

Michiel Morshuis

Volker Rudolph

Jan F Gummert

Henrik Fox

Affiliations

Soon will be listed here.

Abstract

Right heart failure (RHF) is associated with poor outcomes, especially in patients undergoing left ventricular assist device (LVAD) implantation. The aim of this study was to identify predictors of RHF after LVAD implantation. Of 129 consecutive patients (mean age 56 ± 11 years, 89% male) undergoing LVAD implantation, 34 developed RHF. Compared to patients without RHF, those with RHF required longer invasive mechanical ventilation and had longer intensive care unit and hospital stays ( < 0.01). One-year all-cause mortality was significantly higher in patients with versus without RHF after LVAD implantation (29.4% vs. 1.2%; hazard ratio 35.4; 95% confidence interval 4.5-277; < 0.001). Mortality was highest in patients with delayed RHF after initial LVAD-only implantation (66.7%). Patients who did versus did not develop RHF had significantly higher baseline pulmonary vascular resistance (PVR; 404 ± 375 vs. 234 ± 162 dyn/s/cm; = 0.01). PVR > 250 dyn/s/cm was a significant predictor of survival in patients with RHF after LVAD implantation. These data confirm the negative impact of RHF on morbidity and mortality after LVAD implantation. Preoperative PVR > 250 dyn/s/cm determined using invasive right heart catheterization was an independent predictor of developing RHF after LVAD implantation, and of subsequent mortality, and could be used for risk stratification in the setting for deciding between single or biventricular support strategy.

References

Rojas S, Junghans S, Fox H, Lazouski K, Schramm R, Morshuis M . Bacteriophage-Enriched Galenic for Intrapericardial Ventricular Assist Device Infection. Antibiotics (Basel). 2022; 11(5). PMC: 9137613. DOI: 10.3390/antibiotics11050602. View

Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F . The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2021; 22(5):471-479. DOI: 10.1093/ehjci/jeab005. View

Mullan C, Caraballo C, Ravindra N, Miller P, Mori M, McCullough M . Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. J Heart Lung Transplant. 2020; 39(9):926-933. DOI: 10.1016/j.healun.2020.05.007. View

Dandel M, Hetzer R . Echocardiographic assessment of the right ventricle: Impact of the distinctly load dependency of its size, geometry and performance. Int J Cardiol. 2016; 221:1132-42. DOI: 10.1016/j.ijcard.2016.07.014. View

Hoeper M, Badesch D, Ghofrani H, Gibbs J, Gomberg-Maitland M, McLaughlin V . Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023; 388(16):1478-1490. DOI: 10.1056/NEJMoa2213558. View

Sohns C, Fox H, Marrouche N, Crijns H, Costard-Jaeckle A, Bergau L . Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. N Engl J Med. 2023; 389(15):1380-1389. DOI: 10.1056/NEJMoa2306037. View

Savarese G, Becher P, Lund L, Seferovic P, Rosano G, Coats A . Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022; 118(17):3272-3287. DOI: 10.1093/cvr/cvac013. View

Pickett C, Cheezum M, Kassop D, Villines T, Hulten E . Accuracy of cardiac CT, radionucleotide and invasive ventriculography, two- and three-dimensional echocardiography, and SPECT for left and right ventricular ejection fraction compared with cardiac MRI: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2015; 16(8):848-52. DOI: 10.1093/ehjci/jeu313. View

Potapov E, Antonides C, Crespo-Leiro M, Combes A, Farber G, Hannan M . 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg. 2019; 56(2):230-270. PMC: 6640909. DOI: 10.1093/ejcts/ezz098. View

10.

Newman J . Pulmonary Hypertension by the Method of Paul Wood. Chest. 2020; 158(3):1164-1171. DOI: 10.1016/j.chest.2020.02.035. View

11.

Hahn R, Lerakis S, Delgado V, Addetia K, Burkhoff D, Muraru D . Multimodality Imaging of Right Heart Function: JACC Scientific Statement. J Am Coll Cardiol. 2023; 81(19):1954-1973. DOI: 10.1016/j.jacc.2023.03.392. View

12.

Kormos R, Teuteberg J, Pagani F, Russell S, John R, Miller L . Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010; 139(5):1316-24. DOI: 10.1016/j.jtcvs.2009.11.020. View

13.

Fitzpatrick 3rd J, Frederick J, Hsu V, Kozin E, OHara M, Howell E . Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008; 27(12):1286-92. PMC: 3235680. DOI: 10.1016/j.healun.2008.09.006. View

14.

Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R . Multimodality comparison of quantitative volumetric analysis of the right ventricle. JACC Cardiovasc Imaging. 2010; 3(1):10-8. DOI: 10.1016/j.jcmg.2009.09.017. View

15.

Barst R, Rubin L, Long W, McGoon M, Rich S, Badesch D . A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996; 334(5):296-301. DOI: 10.1056/NEJM199602013340504. View

16.

Gual-Capllonch F, Teis A, Ferrer E, Nunez J, Vallejo N, Junca G . Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation. Echocardiography. 2018; 35(11):1736-1745. DOI: 10.1111/echo.14125. View

17.

Gyoten T, Rojas S, Fox H, Hata M, Deutsch M, Schramm R . Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty. Eur J Cardiothorac Surg. 2020; 59(4):855-862. DOI: 10.1093/ejcts/ezaa461. View

18.

Maron B, Brittain E, Hess E, Waldo S, Baron A, Huang S . Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med. 2020; 8(9):873-884. PMC: 8219057. DOI: 10.1016/S2213-2600(20)30317-9. View

19.

Cleveland Jr J, Naftel D, Reece T, Murray M, Antaki J, Pagani F . Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. J Heart Lung Transplant. 2011; 30(8):862-9. DOI: 10.1016/j.healun.2011.04.004. View

20.

Rich J, Gosev I, Patel C, Joseph S, Katz J, Eckman P . The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. J Heart Lung Transplant. 2016; 36(1):50-58. DOI: 10.1016/j.healun.2016.08.010. View